Statement Of Cash Flows [Abstract]

Bayer AG - Filing #6464694

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities	1,222,000 EUR	—	1,298,000 EUR	—	—
Cash flows from (used in) operating activities	7,368,000 EUR	—	5,117,000 EUR	—	—
Cash flows from (used in) investing activities [abstract]
Cash advances and loans made to other parties, classified as investing activities	251,000,000 EUR	—	332,000,000 EUR	—	—
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities	18,000,000 EUR	—	139,000,000 EUR	—	—
Income taxes paid (refund), classified as investing activities	– EUR	—	472,000,000 EUR	—	—
Cash flows from (used in) investing activities	164,000,000 EUR	—	3,517,000 EUR	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control	– EUR	—	23,000,000 EUR	—	—
Payments from changes in ownership interests in subsidiaries that do not result in loss of control	41,000,000 EUR	—	46,000,000 EUR	—	—
Payments to acquire or redeem entity's shares	16,000,000 EUR	—	24,000,000 EUR	—	—
Proceeds from borrowings, classified as financing activities	5,815,000 EUR	—	16,284,000 EUR	—	—
Repayments of borrowings, classified as financing activities	10,833,000 EUR	—	13,031,000 EUR	—	—
Dividends paid, classified as financing activities	131,000,000 EUR	—	2,379,000 EUR	—	—
Interest paid, classified as financing activities	1,977,000 EUR	—	1,537,000 EUR	—	—
Cash flows from (used in) financing activities	7,178,000 EUR	—	679,000,000 EUR	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	68,000,000 EUR	—	185,000,000 EUR	—	—
Cash and cash equivalents	—	6,191,000 EUR	—	5,907,000 EUR	5,171,000 EUR